Recently, RvD1 was reported to alleviate angiotensin II-induced hypertension and cardiac remodeling via blocking Ang II signaling and attenuating inflammation (Olivares-Silva et al., 2021; Salas-Hernández et al., 2021). This evidence concerns the gene AGT and Hypertension.